In response to Paul Pescatello’s opinion, (Connecticut price controls will stifle biopharma innovation), Connecticut residents desperately need the Governor’s bill, HB 6447, to limit out-of-control drug price hikes. The bill isn’t price control; it’s a small step that balances innovation with affordability. Jay Gironimi Anyone who says you can’t put a price on human life […]
